Research monitor / Texas / ibogaine
Texas Research Tracker
A practical map of the Texas-led research pathway: what state action can support, what a registered study can show, and what it does not change about routine use or federal law.
Status overview
Read the program in its proper lane.
Texas policy attention and research funding can create a pathway for institutions to investigate ibogaine under federally compliant research arrangements. They do not, by themselves, make ibogaine an approved treatment or a routine clinical option. For foundational context that sits outside this tracker, the Texas ibogaine overview separates research questions from broader safety and legal questions.
Ibogaine is listed in the federal Schedule I controlled-substances listing. Federal scheduling remains a central boundary: a state may fund or encourage research, while possession, manufacture, distribution, and research handling remain subject to federal requirements.
Study stream
How to audit a study record.
A trial record is the useful starting point—not proof that a study is recruiting, safe for a particular person, or available outside its written protocol. The ClinicalTrials.gov study database is the primary public registry to check for a study’s sponsor, sites, recruitment status, endpoints, criteria, and dates.
Record verification
Required
Active trial entries
As of this tracker page, readers should confirm any claim of an active Texas ibogaine study directly against its current registry entry and the sponsoring institution’s notice. A public statement, a funding announcement, or a legislative directive is not itself a registered trial entry.
- Institution
- Verify in the study sponsor field.
- Trial phase
- Verify in the registered protocol.
- Primary endpoints
- Read the posted outcome measures.
- Eligibility
- Use the study’s plain-language criteria.
- Start date
- Check the current record, not an announcement date.
- Completion date
- Check estimated and actual dates separately.
Planned research
Monitor
Planned studies and funding pathways
Planned work should be described as planned until an official study record identifies a sponsor, protocol, location, recruitment status, and participant criteria. Texas action may help establish a research pathway, but an institutional protocol, appropriate federal permissions, and oversight remain distinct steps.
- Institution
- Look for named sponsoring organizations.
- Trial phase
- Do not infer phase from funding alone.
- Primary endpoints
- Wait for protocol-defined outcomes.
- Eligibility
- Enrollment limits come from the study team.
- Start date
- Use the registry’s first-posted and start fields.
- Completion date
- Treat estimates as subject to change.
Regulatory timeline
Milestones to distinguish, not blur.
Texas legislative action establishes a research-facing direction
Track legislative text, enacted appropriations, and agency or institutional implementation notices separately. A state action can define funding or research intent without changing the federal classification of ibogaine.
Funding allocation is a program signal, not a trial protocol
Budget language can identify a public-policy priority. To understand what work may actually proceed, look next for the administering entity, grant terms, institutional partners, study documents, and federally compliant research approvals.
FDA interaction belongs to the research pathway
For human drug studies, FDA oversight is distinct from state policy. The agency’s Investigational New Drug application overview describes the framework through which sponsors seek authorization to administer an investigational drug in a clinical study.
Program explainer
State-backed research is not routine practice.
Texas can support investigation.
Legislation and appropriations can direct attention, support research infrastructure, or establish a public program. Those actions should be read against their actual text and implementing documents rather than treated as a blanket change in legality.
A study has its own boundaries.
Research participation depends on a particular protocol: its endpoints, screening rules, monitoring plan, investigators, oversight, and enrollment status. A study’s inclusion criteria are not a general recommendation for anyone outside that protocol.
Scheduling still matters.
Federal controlled-substance rules and drug-research requirements continue to apply. The ibogaine reference overview provides general background, but legal and clinical interpretations should rest on current primary sources.
For practical questions about research pathways versus treatment marketing, the scope of Lone Willow’s information services explains the kind of context this resource is designed to provide. For a separate comparison of treatment claims often encountered online, ibogaine treatment and drug addiction information can be read as background, not as evidence that a Texas trial or routine care pathway exists.
Questions in queue
What this tracker can—and cannot—answer.
Does a Texas-backed research program make ibogaine routine medical care?
No. State-backed research and legislative funding can support investigation, but they do not change federal scheduling or make ibogaine routine approved medical care in Texas. For policy-specific interpretation, consult the Texas law and policy brief alongside the underlying statute or budget document.
What should a trial listing be checked for?
Check the official record for recruiting status, locations, eligibility, endpoints, dates, contacts, and sponsor updates. Enrollment decisions belong with the study team. Context from the Texas ibogaine bill tracker may help distinguish legislative developments from a formal study record.
Why are safety screening and monitoring important to this tracker?
Ibogaine has important medical risks, including cardiac concerns described in scientific literature. A research record should be read alongside its protocol safeguards and eligibility limits. The safety considerations guide outlines why legal status does not replace a careful risk discussion.
Can accounts from other places establish what is available in Texas?
No. Accounts such as the Canada-focused ibogaine context or an ibogaine trip experience account may describe different settings, but they do not establish a Texas research protocol, medical standard, or legal pathway. Likewise, material on ibogaine plant seeds does not answer questions about controlled-substance law or clinical research.
Next record
Use the tracker as a starting point, then verify the primary source.
For an overview of Lone Willow’s evidence-first approach, see the organization’s stated mission and principles.